Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Human IgG4 (AS35) (Cat. No. SPD-S68) is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293).

Isotype

Human IgG4/kappa

Specificity

This product is a specific neutralizing antibody against SARS-CoV-2 Spike Protein RBD domain and no cross-reactivity was detected against SARS-CoV Spike protein. The cross-reactivity with other coronaviruses has not been tested yet.

Purity

>95% as determined by SDS-PAGE.

Bioactivity